...Inhibition of gasdermin to prevent inflammatory cell death Origin of technology: Max Planck Institute and Lead Discovery Center GmbH...

...antagonist, in Phase II testing for inflammation and Phase I testing for rheumatoid arthritis (RA). Lead Discovery Center GmbH...

...antagonist EVT401 in Phase II testing for inflammation and Phase I testing for rheumatoid arthritis. Lead Discovery Center GmbH...

...expertise and infrastructure in Germany's North Rhine-Westphalia state. The partners -- Biomedical Center Dortmund , Lead Discovery Center...

...like J&J’s JLABS in Belgium, and organizations such as the U.K.’s Francis Crick Institute, Germany’s Lead Discovery Center GmbH...
...& Johnson (NYSE:JNJ), New Brunswick, N.J. Junction Therapeutics Ltd., Dublin, Ireland Karolinska Institute, Stockholm, Sweden Lead Discovery Center GmbH...
...“Found in translation.” BioCentury Innovations (2016) Lauren Martz, Senior Writer Francis Crick Institute Johnson & Johnson Development Corp. Karolinska Institute Lead Discovery Center GmbH Sofinnova...

...in Phase II testing to treat inflammation and Phase I testing to treat rheumatoid arthritis. Lead Discovery Center GmbH...

...preclinical cancer pipeline with its third PPP since October 2016: a discovery research collaboration with Lead Discovery Center GmbH...
...undisclosed targets that form the basis for the collaboration. Researchers from Max Planck and the Lead Discovery Center...
...Institute (IBRI), Indianapolis, Ind. Indiana University, Indianapolis, Ind. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Lead Discovery Center GmbH...

...Max Planck Society (Munich, Germany) and Lead Discovery Center GmbH (Dortmund, Germany) and Daiichi Sankyo Co. Ltd. (Tokyo:4568) partnered...
...proliferation. Max Planck and Daiichi will fund the discovery portion of the deal at the Lead Discovery Center...
...development and sales milestones as well as royalties. The partners declined to disclose additional details. Lead Discovery Center GmbH...

...Enthera s.r.l. last November from research at San Raffaele Hospital . In addition, the longer-standing Lead Discovery Center GmbH...
...Cancer Preclinical £13.2 ($17) GammaDelta Therapeutics Ltd. (London, U.K.) γδT cell therapies Cancer Preclinical ND Lead Discovery Center GmbH...
...Ltd., Dublin, Ireland Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Kymab Group Ltd., Cambridge, U.K. Lead Discovery Center GmbH...

...P2RX7 antagonist, in Phase II testing for inflammation and Phase I testing for rheumatoid arthritis. Lead Discovery Center GmbH...